DK430683A - Humant immuninterferonprotein samt dets fremstilling og anvendelse - Google Patents

Humant immuninterferonprotein samt dets fremstilling og anvendelse Download PDF

Info

Publication number
DK430683A
DK430683A DK430683A DK430683A DK430683A DK 430683 A DK430683 A DK 430683A DK 430683 A DK430683 A DK 430683A DK 430683 A DK430683 A DK 430683A DK 430683 A DK430683 A DK 430683A
Authority
DK
Denmark
Prior art keywords
immuninterferon
humant
protein
preparation
immuninterferon protein
Prior art date
Application number
DK430683A
Other languages
English (en)
Other versions
DK430683D0 (da
DK164063B (da
DK164063C (da
Inventor
Masakazu Kikuchi
Kyozo Tsukamoto
Tsutomu Kurokawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK430683D0 publication Critical patent/DK430683D0/da
Publication of DK430683A publication Critical patent/DK430683A/da
Publication of DK164063B publication Critical patent/DK164063B/da
Application granted granted Critical
Publication of DK164063C publication Critical patent/DK164063C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK430683A 1982-11-22 1983-09-21 Fremgangsmaade til fremstilling af praktisk taget rent uglycosyleret rekombinant humant immuninterferonprotein DK164063C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8200445 1982-11-22
PCT/JP1982/000445 WO1984002129A1 (en) 1982-11-22 1982-11-22 Human immune interferon protein and process for its preparation

Publications (4)

Publication Number Publication Date
DK430683D0 DK430683D0 (da) 1983-09-21
DK430683A true DK430683A (da) 1984-05-23
DK164063B DK164063B (da) 1992-05-04
DK164063C DK164063C (da) 1992-09-28

Family

ID=13762365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK430683A DK164063C (da) 1982-11-22 1983-09-21 Fremgangsmaade til fremstilling af praktisk taget rent uglycosyleret rekombinant humant immuninterferonprotein

Country Status (18)

Country Link
EP (1) EP0110044A1 (da)
JP (4) JPS59186995A (da)
KR (1) KR920001377B1 (da)
AU (1) AU570219B2 (da)
DK (1) DK164063C (da)
ES (1) ES527414A0 (da)
FI (1) FI81832C (da)
GR (1) GR79035B (da)
HU (1) HU209152B (da)
IE (1) IE57053B1 (da)
IL (1) IL69791A (da)
MC (1) MC1553A1 (da)
NO (1) NO169725C (da)
NZ (1) NZ205667A (da)
PH (1) PH20024A (da)
PT (1) PT77573B (da)
WO (1) WO1984002129A1 (da)
ZA (1) ZA837057B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
DE3426077A1 (de) * 1984-07-14 1986-01-23 Dr. Karl Thomae Gmbh, 7950 Biberach Monoklonale antikoerper gegen humanes ifn-(gamma), diese antikoerper produzierende hybridzellinien, verwendung der neuen antikoerper und verfahren zu deren herstellung
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
JPH0653067B2 (ja) * 1984-09-11 1994-07-20 武田薬品工業株式会社 新規ハイブリドーマおよびその製造法
GB2164650A (en) * 1984-09-25 1986-03-26 Fujisawa Pharmaceutical Co Process for production of y-interferon
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
US4873312A (en) * 1985-04-25 1989-10-10 Amgen Method for purifying interferon and composition of matter produced thereby
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
GB8719108D0 (en) * 1987-08-12 1987-09-16 Natural Environment Res Expression vectors
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
YU32402A (sh) 1999-11-12 2005-03-15 Maxygen Holdings Ltd. Konjugati gama interferona
IL149267A0 (en) 1999-11-12 2002-11-10 Maxygen Holdings Ltd Interferon gamma conjugates
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
AU2003239774A1 (en) 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
CN101124243A (zh) 2004-12-23 2008-02-13 莫尔梅德股份有限公司 缀合产物
US20090148435A1 (en) 2007-10-30 2009-06-11 Genentech, Inc. Antibody purification by cation exchange chromatography

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
US4376821A (en) * 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548U (ja) * 1982-01-22 1983-07-28 株式会社東海理化電機製作所 自動車用ミラ−の駆動装置
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JP2526750B2 (ja) * 1991-07-30 1996-08-21 株式会社ユアサコーポレーション リチウム二次電池

Also Published As

Publication number Publication date
JPS59220190A (ja) 1984-12-11
ZA837057B (en) 1984-04-25
DK430683D0 (da) 1983-09-21
AU570219B2 (en) 1988-03-10
FI833525A0 (fi) 1983-09-29
KR840006676A (ko) 1984-12-01
KR920001377B1 (ko) 1992-02-11
NO169725B (no) 1992-04-21
HU209152B (en) 1994-03-28
DK164063B (da) 1992-05-04
JPS6411639B2 (da) 1989-02-27
PT77573A (en) 1983-11-01
PT77573B (en) 1986-03-18
AU1934683A (en) 1984-06-28
IE57053B1 (en) 1992-04-08
FI833525A (fi) 1984-05-23
EP0110044A1 (en) 1984-06-13
FI81832B (fi) 1990-08-31
JPH0536414B2 (da) 1993-05-31
NO833659L (no) 1984-05-23
ES8504938A1 (es) 1985-04-16
PH20024A (en) 1986-09-01
NZ205667A (en) 1987-01-23
NO169725C (no) 1992-07-29
IL69791A (en) 1994-05-30
DK164063C (da) 1992-09-28
FI81832C (fi) 1990-12-10
JPS59186995A (ja) 1984-10-23
IE832216L (en) 1984-05-22
MC1553A1 (fr) 1984-08-31
ES527414A0 (es) 1985-04-16
GR79035B (da) 1984-10-02
JPS63211240A (ja) 1988-09-02
JPH06316532A (ja) 1994-11-15
WO1984002129A1 (en) 1984-06-07

Similar Documents

Publication Publication Date Title
DK430683A (da) Humant immuninterferonprotein samt dets fremstilling og anvendelse
NO168116C (no) Hydrolyserbart harpikspreparat og dets anvendelse
DK522383D0 (da) Aluminium-n-phosphonomethylglycin og dets anvendelse som herbicid
DK468685D0 (da) Liposom-gel-materiale og dets anvendelse
DK47285A (da) Renininhiberende peptider og anvendelsen deraf
IT1167391B (it) Carbossi e carbossi sostituiti alcanoil e cicloalcanoil peptidi
DK144483A (da) Barbermaskine og barberingsenhed for barbermaskiner
AT388857B (de) Organisations- und griffleiste
DK600586A (da) Protein
DK311884D0 (da) Calcitoninforbindelse samt fremstilling og anvendelse deraf
DK35884A (da) Lactampeptider samt deres fremstilling og anvendelse
DK280085D0 (da) 7alfa-acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner samt deresfremstilling og anvendelse
NO880186L (no) Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.
DK162804C (da) Dinitroanilinpraeparat samt dettes fremstilling
DK158844C (da) Saltsyrepraeparater og anvendelse heraf
DK189584D0 (da) (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK419084D0 (da) 2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK358882A (da) Anthracyclinantibiotica samt deres fremstilling og anvendelse
DK35984A (da) Lactampeptider samt deres fremstilling og anvendelse
DK522883A (da) 2-heterocyclylthio-alkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK321584A (da) Haerder samt anvendelse deraf
DK613984A (da) 2-heterocyclyl-6-hydroxylavalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK162607C (da) Azopigmentpraeparater og deres anvendelse
DK363786D0 (da) Hydroquinoliner og anvendelse deraf
DK550686A (da) Polyurethangelmateriale og dets anvendelse

Legal Events

Date Code Title Description
PBP Patent lapsed